CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		59 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Revenue
Diagnostic testing services	$ 24,124	$ 169,230	$ 908,644
Product sales	0	13,440	231,380
Total revenue	24,124	182,670	1,140,024
Cost of revenue
Diagnostic testing services	0	47,599	141,509
Product sales	0	18,865	244,919
Total cost of revenue	0	66,464	386,428
Loss on obsolete inventory & LCM	0	0	271,856
Gross profit	24,124	116,206	481,740
Selling expenses	237,838	272,575	2,135,505
Research and development expenses	422,503	220,192	5,084,999
General and administrative expenses	1,774,708	1,564,872	16,155,879
Total operating expenses	2,435,049	2,057,639	23,376,383
Operating loss	(2,410,925)	(1,941,433)	(22,894,643)
Interest income	143	0	7,026
Interest expense	749	7	40,280
Net loss before income taxes	(2,411,531)	(1,941,440)	(22,927,897)
Income taxes	0	0	248
Net loss	$ (2,411,531)	$ (1,941,440)	$ (22,928,145)
Loss per common share - basic and diluted (in dollars per share)	$ (0.10)	$ (0.14)	$ (2.16)
Weighted average shares outstanding, basic & diluted (in shares)	24,419,060	13,421,119	10,604,575